Greg Finak

CEO co-founder at Ozette Technologies
[email protected]

[Greg Finak @GregFinak]

Applying the Ozette Discovery™ algorithm to CITE-seq data uncovers changes in abundance of early cellular biomarkers and associated transcriptional changes linked to later COVID disease severity.
https://t.co/QMqv0wy4hK
https://t.co/iT6w8QtzeO

[Ozette @OzetteTech]

We’re collaborating w/pioneers in #cancerbiology, @UmojaBiopharma, to accelerate biomarker discovery in preclinical studies.

More on our shared mission to increase drug development efficiency & expand access to lifesaving #immunotherapies: @YahooFinance➡️ https://t.co/wG6gU4Vgxo

[Ozette @OzetteTech]

👋 At #CYTO2023? Join us tonight for happy hour at Intercontinental Montréal!

We look forward to raising a glass & catching up with colleagues and friends.

RSVP here: https://t.co/AwJErqzlXs

[Ozette @OzetteTech]

📢 Introducing our suite of #ML-powered applications combining world-class data generation, rapid computational monitoring of pre-defined biomarker #endpoints, & unbiased #discovery & annotation of single-cell #cytometry data.  

@bloomberg ➡️ https://t.co/Iq5Kfrr5rd

#CYTO2023

[Ozette @OzetteTech]

Join Mike and the Ozette team at #CYTO2023 in Montréal, May 20-24, to explore our science & technology up close. https://t.co/0vKm0k1HD0

[Ozette @OzetteTech]

➡️Dr. Ashley Wilson to spearhead Ozette #immunology lab➡️https://t.co/0G5ceG4fpS

Ashley joins us w/deep industry expertise from @SCTherapeutics. Here, she'll help our partners drive breakthroughs by capturing the full value of #singlecell data at unparalleled speed & resolution.

[Dillon Hammill @DillonHammill]

Super excited to be joining the team @OzetteAI this week. Looking forward to improving patient outcomes by leveraging and developing new computational approaches to advance the analysis of single-cell data. Check out the Ozette website to learn more: https://t.co/RTv4iqr50a

[ASGCT @ASGCTherapy]

Stan Riddell MD from @fredhutch will speak on genetically engineered immune cells in #cancer therapy in person during the #ASGCT23 Annual Meeting. Dr. Riddell works on pioneering therapies with genetically reprogrammed #Tcells. Register, early bird price https://t.co/gZ5xQKv89k

[Greg Finak @GregFinak]

@OzetteAI @ScienceMagazine @fredhutch My part in this was small compared to the efforts of collaborators. Congrats really go out to that amazing team. It was an honor to work with them all.

[Bloom Lab @jbloom_lab]

It’s easy to understand why it took longer for variants to emerge at site 486: mutations at 486 reduce ACE2 affinity, so benefit they provide in antibody escape comes at cost to receptor binding. See below for our deep mutational scanning data from https://t.co/rpldkk8P2r

[SwissCytoMeeting @SwissCytometry]

Prof. Raphael Gottardo from @FBM_UNIL will talk about "Dissecting responses to immunotherapy using high-dimensional single-cell analysis"

https://t.co/3CIXAyUt9q

#SCM2023 #flowcytometry

[Greg Finak @GregFinak]

Humbled to have had the opportunity to contribute to this work with an incredible team of collaborators. @OzetteAI open-source #cytoverse tools used for reproducible flow cytometry analysis. https://t.co/JS0ShHBfLL

[Ozette @OzetteTech]

We’re honored to welcome immuno-oncology pioneer Dr. Stanley Riddell to our Board. His expertise in biomedical science & #translationalmedicine help guide our team's vision to transform #singlecell data into actionable insights for better immunotherapies.

https://t.co/Yt9X9XT5FI

[Ozette @OzetteTech]

Employee Spotlight: meet Andrew McDavid (@EquivMeasures), Principal Research Scientist. Before joining Ozette, he developed methods for #singlecell gene expression experiments w/@fredhutch & was an associate professor of #biostatistics at @UofR.

More ▶️ https://t.co/jl0bsd0HTD

[Greg Finak @GregFinak]

Thrilled to share that @OzetteAI is @BioTech_Awards’ 2022 Overall Immunology Company of the Year! We’re unlocking the full value of modern #singlecell data w/ computational solutions that are transparent, interactive & deliver fully annotated results to maximize immune insights.

[Ozette @OzetteTech]

We’re thrilled to be honored as @BioTech_Awards’ 2022 Overall Immunology Company of the Year. Congratulations to our dedicated team for their breakthrough discoveries accelerating the next wave of #singlecell immune insights!

[Ozette @OzetteTech]

We’re proud to share that Ozette co-founder and Scientific Advisor @raphg will serve as co-PI in the @ChanZuckerberg’s single-cell standardization & annotation project to capture the breadth & depth of true biological variation.

https://t.co/pzWdZUyWxi

[Ozette @OzetteTech]

We’re honored to welcome Amarjit Kaur Sandhu to Ozette as VP of Engineering. A veteran thought leader in #healthtech software development, she will spearhead software engineering & the delivery of #singlecell solutions for our partners.

More @geekwire 👇
https://t.co/4Sp5MxZ9Fo

[Ozette @OzetteTech]

“Ultimately, whether someone is healthy or sick, we want Ozette to be a key part in giving insights into what’s happening.” -Ozette CEO @aliansary

The story on our $26M Series A & what’s next from @aayushipratap in @endpts: https://t.co/NAY9xTJcn8

[Greg Finak @GregFinak]

@OzetteAI just raised $26M in Series A funding! The details in @Geekwire: https://t.co/JCrXRXo6LS #immunology #aiforgood

[Greg Finak @GregFinak]

Incredibly proud of the team at Ozette and congratulations on this milestone!

[Ozette @OzetteTech]

We just announced our $26M Series A w/ @MadronaVentures, Cercano & @M12vc for faster, more reliable #singlegell analysis. The story via @Geekwire/@schubertcm: https://t.co/9rhU3MopmB